ArticleEuropean journal of radiology2025
Malignancy rate of lesions presenting as architectural distortion on DBT related to accompanied features, ultrasound findings, and BI-RADS density.
Article in European journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivesTo compare the malignancy rate of architectural distortion (AD) on DBT, shown as the prominent feature or as the associated feature coexisting with other significant radiological findings.
methods537 diagnostic patients who had symptoms or abnormal imaging findings were analyzed, 305 malignant and 232 benign. They were selected based on the original DBT report mentioning AD. Two fellowship-trained radiologists reviewed images and gave BI-RADS scores using a full range of 3-5, and determined whether the AD was the dominant feature or an associated feature. The original ultrasound (US) reports were reviewed to determine whether there were corresponding abnormalities and obtain the US BI-RADS scores for correlation with DBT results.
results230 cases were associated AD accompanying masses or highly suspicious microcalcifications, and the malignancy rate was 78 % (180/230). 307 cases were determined as the prominent AD with a significantly lower 41 % malignancy rate (125/307, p < 0.001). In the prominent AD group, the malignancy rate was 32/47 = 68 % when accompanied by intermediate-risk calcifications, 27/63 = 43 % with regional high-density, and 66/197 = 34 % in pure AD. Of them, 237 had corresponding US findings, and 70 cases did not, and the malignancy rate was 109/237 = 46 % vs. 16/70 = 23 %, higher when there were US correlates, p = 0.001.
conclusionAD shown on DBT may be accompanied by other radiological features related to mass, density, and different suspicious levels of microcalcifications, and the malignancy rates were different. Information from other supplementary imaging may help determine optimized management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.